<result><Target><Item><Target_ID> 1626</Target_ID>
<Target_Name>Histone demethylase KDM1A</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1627</Target_ID>
<Target_Name>Histone demethylase KDM1B</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1628</Target_ID>
<Target_Name>Histone demethylase KDM4A</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1629</Target_ID>
<Target_Name>Histone demethylase KDM4C</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1630</Target_ID>
<Target_Name>Human brain-seeking breast carcinoma cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>231-BR cells</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1631</Target_ID>
<Target_Name>Enantiomeric Lipid I(ent-Lipid I)</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Phage display screens made use of lipid I inspired targets in both natural and enantiomeric forms. First, by doing so the amount of chemical space explored in the screen is effectively doubled. Secondly, it was considered that L-peptides selected in the screen that possess high affinity for natural lipidI/II might in fact be toxic towards the E.coli used in the amplification step of the phage display experiment, so using enantiomeric forms  was viewed as a way of avoiding any such negative selection bias.</Comments>
</Item><Item><Target_ID> 1632</Target_ID>
<Target_Name>Myoglobin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P02144</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>3RGK</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1633</Target_ID>
<Target_Name>Anti-TsCa IgG</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The total IgG from 120 serologically positive cattle with high titers was purified according to the procedure based on the reactivity against TsCa.</Comments>
</Item><Item><Target_ID> 1634</Target_ID>
<Target_Name>Anti-soluble CD14-fraction ST monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1635</Target_ID>
<Target_Name>Anti-CD14 polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1636</Target_ID>
<Target_Name>Human ovarian adenocarcinoma cell line SKOV-3</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1637</Target_ID>
<Target_Name>Anti-1/3NH2TTPI polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1638</Target_ID>
<Target_Name>Enterobactin synthase component E</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P10378</Target_Sequence>
<Synonyms>Enterochelin synthase E</Synonyms>
<Target_Source>Escherichia coli (strain K12):83333</Target_Source>
<Target_Structure>3RG2, 4IZ6</Target_Structure>
<Comments>The enterobactin biosynthetic enzyme EntA forms a complex with EntE, the next enzyme in the pathway, to enhance activation of the enterobactin precursor 2,3-dihydroxybenzoate.</Comments>
</Item><Item><Target_ID> 1639</Target_ID>
<Target_Name>Vaccinia virus strain NYCBOH</Target_Name>
<Target_Type>Virus</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>VACV strain NYCBOH (VR-1536TM) was purchased from ATCC®.</Comments>
</Item><Item><Target_ID> 1640</Target_ID>
<Target_Name>Surface glycoprotein Tc85-45</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q2VYD6</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Trypanosoma cruzi:5693</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1641</Target_ID>
<Target_Name>Sera IgG from asymptomatic CVL and symptomatic CVL</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Canis familiaris:9615</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1642</Target_ID>
<Target_Name>Anti-GapC monoclonal antibody 1E11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1643</Target_ID>
<Target_Name>3-hydroxy-3-methylglutaryl-coenzyme A reductase ( (EC:1.1.1.34))</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P04035</Target_Sequence>
<Synonyms>HMG-CoA reductase</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1DQ8, 1DQ9, 1DQA, 1HW8, 1HW9, 1HWI, 1HWJ, 1HWK, 1HWL, 2Q1L, 2Q6B, 2Q6C, 2R4F, 3BGL, 3CCT, 3CCW, 3CCZ, 3CD0, 3CD5, 3CD7, 3CDA, 3CDB</Target_Structure>
<Comments>Human HMG-CoA reductase (hHMGR) is the rate-limiting enzyme of the mevalonate pathway that produces cholesterol and other isoprenoids. The enzyme contains 888 amino acids with the first 339 residues as the membrane anchor domain located in the endoplasmic reticulum. A linker region is located between residues ranging from 340 to 449, while the catalytic domain, from residues ranging from 450 to 888, resides in the cytoplasm.</Comments>
</Item><Item><Target_ID> 1644</Target_ID>
<Target_Name>Bone marrow-derived dendritic cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1645</Target_ID>
<Target_Name>9-fluorenylmethoxycarbonyl-threonine and leucine-methyl ester (Fmoc-T/L-OMe)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Fmoc-T was purchased from Sigma-Aldrich and L-OMe.HCl from Fluka.</Comments>
</Item><Item><Target_ID> 1646</Target_ID>
<Target_Name>9-fluorenylmethoxycarbonyl-threonine and leucine-amide (Fmoc-T/L-NH2)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Fmoc-T and L-NH2 were purchased from Sigma-Aldrich.</Comments>
</Item><Item><Target_ID> 1647</Target_ID>
<Target_Name>Cerebrospinal fluid</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1648</Target_ID>
<Target_Name>Anti-Lpp20 monoclonal antibody L001</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1649</Target_ID>
<Target_Name>Anti-EGFR monoclonal antibody ICR-62</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1650</Target_ID>
<Target_Name>Tumor necrosis factor</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01375</Target_Sequence>
<Synonyms>Cachectin
TNF-alpha
Tumor necrosis factor ligand superfamily member 2
TNF-α</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A8M, 1TNF, 2AZ5, 2E7A, 2TUN, 2ZJC, 2ZPX, 3ALQ, 3IT8, 3L9J, 3WD5, 4G3Y, 4TSV, 5TSW</Target_Structure>
<Comments></Comments>
</Item></Target></result>